Hillary Clinton Takes Down the iShares Nasdaq Biotechnology: Buy the News?

The shot was heard around the world of biotech: Price gouging like this in the specialty drug market is outrageous. Tomorrow I'll lay out a plan to take it on. -H https://t.co/9Z0Aw7aI6h — Hillary Clinton (@HillaryClinton) September 21, 2015 The reaction was immediate and sharp for iShares Nasdaq Biotechnology (IBB) as it lost 4.6% on … Read more

The (Limited?) Opportunity for Regulatory Renewal

The never-ending debate about government regulations has recently inherited an intriguing level of urgency with the economy stalled and both major political parties targeting regulations as potential impediments to growth. The Obama administration announced plans to remove regulations that it estimated would save businesses $5 billion over five years. In an all too predictable partisan … Read more